title: Thrombin generation assays for optimizing low molecular weight heparin dosing in pregnant women at risk of thrombosis--response to Ismail et al.
authors.affiliation: Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free Hospital, London, UK. p.chowdary@nhs.net.
authors.forename: Pratima
authors.initials: P
authors.lastname: Chowdary
authors.affiliation: Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free Hospital, London, UK.
authors.forename: Anne
authors.initials: A
authors.lastname: Riddell
authors.affiliation: Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free Hospital, London, UK.
authors.forename: Collen
authors.initials: C
authors.lastname: Hamid
authors.affiliation: Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free Hospital, London, UK.|Department of Haemato-Oncology, Mater Dei Hospital, Msida, Malta.
authors.forename: Alex
authors.initials: A
authors.lastname: Gatt
mesh_terms: D000925:Anticoagulants; D065427:Factor Xa Inhibitors / Q000097:blood*; D005260:Female; D006495:Heparin, Low-Molecular-Weight; D006801:Humans; D008991:Monitoring, Physiologic; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D019851:Thrombophilia
chemical_list: D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight
keywords: anti-Xa; heparin; pregnancy; thrombin generation assay